Prognosis of cirrhotic patients admitted to the general ICU - PubMed (original) (raw)
Prognosis of cirrhotic patients admitted to the general ICU
Gaël Piton et al. Ann Intensive Care. 2016 Dec.
Abstract
Background: The prognosis of cirrhotic patients admitted to the ICU is considered to be poor but has been mainly reported in liver ICU. We aimed to describe the prognosis of cirrhotic patients admitted to a general ICU, to assess the predictors of mortality in this population, and, finally, to identify a subgroup of patients in whom intensive care escalation might be discussed.
Results: We performed a retrospective monocentric study of all cirrhotic patients consecutively admitted between 2002 and 2014 in a general ICU in a regional university hospital. Two hundred and eighteen cirrhotic patients were admitted to the ICU. The 28-day and 6-month mortality rates were 53 and 74 %, respectively. Among the 115 patients who were discharged from ICU, only eight patients underwent liver transplantation, whereas 48 had no clear contraindication. Multivariable analyses on 28-day mortality identified three independent variables, incorporated into a new three-variable prognostic model as follows: SOFA ≥ 12 (OR 4.2 [2.2-8.0]; 2 points), INR ≥ 2.6 (OR 2.5 [1.3-4.8]; 1 point), and renal replacement therapy (OR 2.3 [1.1-5.1]; 1 point). For a value of the score at 4 (16 % of patients), 28-day and 3-month mortality rates were 91 and 100 %, respectively. An external validation of the score among 149 critically ill cirrhotic patients showed a good accuracy for predicting in-ICU mortality.
Conclusions: Mortality of cirrhotic patients admitted to a general ICU was comparable to that of other studies. A pragmatic score integrating the SOFA score, INR, and the need for extrarenal epuration was strongly associated with mortality. Among the 16 % of patients presenting with score 4 at ICU admission, 100 % died in the 3-month follow-up period. The prognostic evaluation on day 3 remains essential for the majority of patients. However, this score calculable at ICU admission might identify patients in whom the benefit of intensive care escalation should be discussed, in particular when liver transplantation is contraindicated.
Figures
Fig. 1
Survival according to our three-variable prognostic score
Similar articles
- Prognostic scores for cirrhotic patients admitted to an intensive care unit: which consequences for liver transplantation?
Galbois A, Das V, Carbonell N, Guidet B. Galbois A, et al. Clin Res Hepatol Gastroenterol. 2013 Nov;37(5):455-66. doi: 10.1016/j.clinre.2013.05.001. Epub 2013 Jun 15. Clin Res Hepatol Gastroenterol. 2013. PMID: 23773487 - Prognosis of cirrhotic patients admitted to intensive care unit: a meta-analysis.
Weil D, Levesque E, McPhail M, Cavallazzi R, Theocharidou E, Cholongitas E, Galbois A, Pan HC, Karvellas CJ, Sauneuf B, Robert R, Fichet J, Piton G, Thevenot T, Capellier G, Di Martino V; METAREACIR Group. Weil D, et al. Ann Intensive Care. 2017 Dec;7(1):33. doi: 10.1186/s13613-017-0249-6. Epub 2017 Mar 21. Ann Intensive Care. 2017. PMID: 28321803 Free PMC article. - Outcome scoring systems for short-term prognosis in critically ill cirrhotic patients.
Tu KH, Jenq CC, Tsai MH, Hsu HH, Chang MY, Tian YC, Hung CC, Fang JT, Yang CW, Chen YC. Tu KH, et al. Shock. 2011 Nov;36(5):445-50. doi: 10.1097/SHK.0b013e31822fb7e2. Shock. 2011. PMID: 21841535 - Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics.
Cholongitas E, Senzolo M, Patch D, Shaw S, Hui C, Burroughs AK. Cholongitas E, et al. Aliment Pharmacol Ther. 2006 Aug 1;24(3):453-64. doi: 10.1111/j.1365-2036.2006.02998.x. Aliment Pharmacol Ther. 2006. PMID: 16886911 Review. - Cirrhotic patients in the ICU: prognostic markers and outcome.
Saliba F, Ichai P, Levesque E, Samuel D. Saliba F, et al. Curr Opin Crit Care. 2013 Apr;19(2):154-60. doi: 10.1097/MCC.0b013e32835f0c17. Curr Opin Crit Care. 2013. PMID: 23426137 Review.
Cited by
- Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit Treatment.
Nagel M, Westphal R, Hilscher M, Galle PR, Schattenberg JM, Schreiner O, Labenz C, Wörns MA. Nagel M, et al. Medicina (Kaunas). 2023 Apr 29;59(5):866. doi: 10.3390/medicina59050866. Medicina (Kaunas). 2023. PMID: 37241098 Free PMC article. - Impact of liver cirrhosis on ST-elevation myocardial infarction related shock and interventional management, a nationwide analysis.
Dar SH, Rahim M, Hosseini DK, Sarfraz K. Dar SH, et al. World J Hepatol. 2022 Apr 27;14(4):766-777. doi: 10.4254/wjh.v14.i4.766. World J Hepatol. 2022. PMID: 35646267 Free PMC article. - Outcomes of cirrhotic patients admitted to the intensive care unit after a successful cardiac arrest resuscitation.
Alkhlewi MN, Al-Dorzi HM, Alenezi FZ, Farhat AM, Tamim H, Sadat M, Humaid FB, Arabi YM. Alkhlewi MN, et al. Saudi Med J. 2021 Dec;42(12):1320-1324. doi: 10.15537/smj.2021.42.12.20210478. Saudi Med J. 2021. PMID: 34853137 Free PMC article. - Assessing the prognosis of cirrhotic patients in the intensive care unit: What we know and what we need to know better.
da Silveira F, Soares PHR, Marchesan LQ, da Fonseca RSA, Nedel WL. da Silveira F, et al. World J Hepatol. 2021 Oct 27;13(10):1341-1350. doi: 10.4254/wjh.v13.i10.1341. World J Hepatol. 2021. PMID: 34786170 Free PMC article. Review. - Acid-base status and its clinical implications in critically ill patients with cirrhosis, acute-on-chronic liver failure and without liver disease.
Drolz A, Horvatits T, Roedl K, Rutter K, Brunner R, Zauner C, Schellongowski P, Heinz G, Funk GC, Trauner M, Schneeweiss B, Fuhrmann V. Drolz A, et al. Ann Intensive Care. 2018 Apr 19;8(1):48. doi: 10.1186/s13613-018-0391-9. Ann Intensive Care. 2018. PMID: 29675709 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources